Biomark Diagnostics Inc. (FRA:20B)
Germany · Delayed Price · Currency is EUR 0.3160
0.00 (0.00%)
Last updated: Jun 15, 2026, 8:06 AM CET
Biomark Diagnostics Market Cap
Biomark Diagnostics has a market cap or net worth of €33.65 million as of June 15, 2026. Its market cap has increased by 91.73% in one year.
Market Cap
33.65M
Enterprise Value
33.29M
Revenue
57.01K
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.32
Market Cap Chart
Since November 27, 2014, Biomark Diagnostics's market cap has increased from 28.50M to 33.65M, an increase of 18.08%. That is a compound annual growth rate of 1.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 15, 2026 | 33.65M | 3.29% |
| Dec 30, 2025 | 32.58M | 228.85% |
| Dec 30, 2024 | 9.91M | -19.08% |
| Dec 29, 2023 | 12.24M | 23.53% |
| Dec 30, 2022 | 9.91M | -23.89% |
| Dec 30, 2021 | 13.02M | 134.71% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Biotest GmbH & Co. KGaA | 1.27B |
| Darwin AG | 72.00M |
| 2invest AG | 47.16M |
| Vidac Pharma Holding | 28.81M |
| co.don AG | 400.85K |
| Paion AG | 378.09K |
| bioXXmed AG | 222.93K |
| MagForce AG | 91.72K |